- Home
- NTRP vs SNGX Comparison
NTRP vs SNGX Comparison
Compare NTRP & SNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTRP
- SNGX
- Stock Information
- Founded
- NTRP 1985
- SNGX 1987
- Country
- NTRP United States
- SNGX United States
- Employees
- NTRP N/A
- SNGX N/A
- Industry
- NTRP
- SNGX Biotechnology: Pharmaceutical Preparations
- Sector
- NTRP
- SNGX Health Care
- Exchange
- NTRP NYSE
- SNGX Nasdaq
- Market Cap
- NTRP 6.7M
- SNGX 6.1M
- IPO Year
- NTRP N/A
- SNGX 1987
- Fundamental
- Price
- NTRP $5.32
- SNGX $2.08
- Analyst Decision
- NTRP Hold
- SNGX
- Analyst Count
- NTRP 1
- SNGX 0
- Target Price
- NTRP $5.00
- SNGX N/A
- AVG Volume (30 Days)
- NTRP 45.3K
- SNGX 29.1K
- Earning Date
- NTRP 04-15-2025
- SNGX 05-09-2025
- Dividend Yield
- NTRP N/A
- SNGX N/A
- EPS Growth
- NTRP N/A
- SNGX N/A
- EPS
- NTRP N/A
- SNGX N/A
- Revenue
- NTRP $623,664.00
- SNGX $119,371.00
- Revenue This Year
- NTRP $354.28
- SNGX N/A
- Revenue Next Year
- NTRP $536.37
- SNGX N/A
- P/E Ratio
- NTRP N/A
- SNGX N/A
- Revenue Growth
- NTRP 186.93
- SNGX N/A
- 52 Week Low
- NTRP $1.39
- SNGX $1.83
- 52 Week High
- NTRP $8.50
- SNGX $14.88
- Technical
- Relative Strength Index (RSI)
- NTRP 53.73
- SNGX 35.08
- Support Level
- NTRP $5.01
- SNGX $2.25
- Resistance Level
- NTRP $6.48
- SNGX $2.28
- Average True Range (ATR)
- NTRP 0.69
- SNGX 0.12
- MACD
- NTRP 0.11
- SNGX -0.02
- Stochastic Oscillator
- NTRP 54.55
- SNGX 8.42
About NTRP NEXTTRIP INC
NextTrip Inc is a technology-driven platform delivering travel booking and travel media solutions. It provides individual and group travelers with vacations to popular and sought-after destinations in Mexico, the Caribbean, and across the world. NextTrip Media platform - Travel Magazine offers a social media platform for viewers to explore, educate, and share with friends their bucket list travel. The company is also launching an end-to-end content ecosystem that uses AI-assisted travel planning capturing advertising, building brand awareness, rewarding loyalty, and driving bookings.
About SNGX Soligenix Inc.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).